Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

10 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Cycle Dose Drug Form (D2R) Endometrial Cancer (NCT00942357)

- 09-01-15 - 1 Formulier, 3 Itemgroepen, 38 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, TREATMENT CYCLE AND MODIFICATION, Pretreatment hematology and chemistry values
GOG-0258 Cycle Dose Drug Form (D2R) Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer NCT00942357 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=644E6D14-3E4C-95F3-E040-BB89AD4357FF

Cycle Dose Drug Form (D2R) Ovarian Cancer (NCT00954174)

- 09-01-15 - 1 Formulier, 3 Itemgroepen, 38 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, TREATMENT CYCLE AND MODIFICATION, Pretreatment hematology and chemistry values
GOG-0261: Cycle Dose Drug Form (D2R) Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer NCT00954174 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=64F29740-0457-692F-E040-BB89AD432164

Treatment Chemotherapy-docetaxel/capecitabine arm Breast Cancer NCT00433589

- 29-07-15 - 1 Formulier, 2 Itemgroepen, 19 Data-elementen, 1 Taal
Itemgroepen: Header, Chemotherapy Anthracycline Arm
Treatment Chemotherapy-docetaxel/capecitabine arm Breast Cancer NCT00433589 Breast Cancer NCT00433589 Treatment - Chemotherapy-docetaxel/capecitabine arm - 2499349v1.0 Chemotherapy-docetaxel/capecitabine arm Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes NCT00433589 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=196E5474-4AF3-680E-E044-0003BA3F9857

Breast Cancer DRUG SUPPLY NCT00024102 CALGB 49907 - CAPECITABINE DRUG SUPPLY RECORD FORM NCT00024102

- 20-05-15 - 1 Formulier, 2 Itemgroepen, 22 Data-elementen, 1 Taal
Itemgroepen: Header, Drug Supply
CALGB: 49907 CAPECITABINE DRUG SUPPLY RECORD FORM Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer NCT00024102 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A50CE624-6F5F-37E3-E034-080020C9C0E0

Breast Cancer combination chemotherapies (NCT00024102) - CYCLOPHOSPHAMIDE MEDICATION CALENDAR (CALGB 49907, NCT00024102)

- 18-03-15 - 1 Formulier, 2 Itemgroepen, 15 Data-elementen, 1 Taal
Itemgroepen: Header, Medication calendar
Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer NCT00024102 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A50CFEAE-D13B-3952-E034-080020C9C0E0

Breast Cancer NCT00024102 Transmittal - CALGB 49907 CAPECITABINE DRUG SUPPLY RECORD FORM 2044684_v3_0 - CALGB: 49907 CAPECITABINE DRUG SUPPLY RECORD FORM

- 16-12-14 - 1 Formulier, 2 Itemgroepen, 22 Data-elementen, 2 Talen
Itemgroepen: General information, Medication
CALGB: 49907 CAPECITABINE DRUG SUPPLY RECORD FORM Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A50CE624-6F5F-37E3-E034-080020C9C0E0

Cycle Dose Drug Form (D2R) GOG-0241

- 22-08-15 - 1 Formulier, 3 Itemgroepen, 42 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, TREATMENT CYCLE AND MODIFICATION, Pretreatment hematology and chemistry values
GOG-0241 Cycle Dose Drug Form (D2R) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Cycle Dose Drug Form (D2R) GOG-0262

- 22-08-15 - 1 Formulier, 4 Itemgroepen, 38 Data-elementen, 1 Taal
Itemgroepen: HEADER MODULE, TREATMENT CYCLE AND MODIFICATION, Pretreatment hematology and chemistry values, COMMENTS
Cycle Dose Drug Form (D2R) GOG-0262 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Anal Cancer NCT00324415 Treatment - AMC-045 Study Drug Therapy Form (SDT) - 2514584v1.0 - AMC-045 Study Drug Therapy Form (SDT)

- 09-01-15 - 1 Formulier, 3 Itemgroepen, 11 Data-elementen, 1 Taal
Itemgroepen: Header Module, Cycle and Dose Modification, Comments
AMC-045 Study Drug Therapy Form (SDT) Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1BB1575F-CA34-29C3-E044-0003BA3F9857

Efficacy and Safety of Pazopanib (GW786034) in Subjects With Advanced Non-Small Cell Lung Cancer NCT00549328 - Screening - Subject Identification; Demography; Disease Characteristics; Status at Screening; Anti-Cancer Therapy; Anti-Cancer Radiotherapy; Medical Conditions

- 15-03-21 - 1 Formulier, 12 Itemgroepen, 64 Data-elementen, 1 Taal
Itemgroepen: Inform Screening, Subject number, Date of Visit/ Assessment, Local Laboratories, Subject identification, Demography, Disease Characteristics, Metastatic Disease, Status at Screening, Anti-Cancer Therapy, Anti-Cancer Therapy , Medical Conditions
Study ID: 109609 Clinical Study ID: 109609 Study Title: A Phase II, Non-randomized, Multi-center Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) in Subjects With Advanced Non-Small Cell Lung Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00549328 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: GW786034 Trade Name: Drug: Pazopanib Study Indication: Lung Cancer, Non-Small Cell

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial